USE OF URSODEOXYCHOLIC ACID CAN BE OPTIMIZED IN A NATIONWIDE COHORT OF PATIENTS WITH PRIMARY BILIARY CHOLANGITIS

被引：0

作者：

Werner, Ellen ^{[1
]}

van Hooff, Maria C. B. ^{[1
]}

Van de Vrie, Maria A. ^{[1
]}

Weijsters, Gemma H. X. ^{[1
]}

de Veer, Rozanne C. ^{[1
]}

Beuers, Ulrich ^{[2
]}

Drenth, Joost P. H. ^{[2
]}

Cuperus, Frans J. C. ^{[3
]}

van Dijk, Remco ^{[4
]}

Veldt, Bart J. ^{[5
]}

Klemt-Kropp, Michael ^{[6
]}

van Meer, Suzanne ^{[7
]}

Verdonk, Robert ^{[8
]}

Flink, Hajo J. ^{[9
]}

Vrolijk, Jan Maarten ^{[10
]}

Gevers, Tom J. G. ^{[11
]}

Ponsioen, Cyriel Y.

Boonstra, Kirsten ^{[12
]}

Boersma, Femke ^{[13
]}

de Jonge, Hendrik J. M. ^{[14
]}

Wolfhagen, Frank ^{[15
]}

Baak, L. C. ^{[16
]}

Onderwater, Susanne L. ^{[17
]}

van Bergeijk, Jeroen D. ^{[18
]}

van Putten, Paul G. ^{[19
]}

de Bruin, Gijs ^{[20
]}

Adang, Robert ^{[21
]}

Aparicio-Pages, Maria N. ^{[22
]}

de Boer, Wink ^{[23
]}

ter Borg, Frank ^{[24
]}

van Soest, Hanneke ^{[25
]}

de Vries, Elsemieke S. ^{[26
]}

Janssen, Harry L. A. ^{[1
]}

Hansen, Bettina E. ^{[1
]}

Erler, Nicole S. ^{[1
]}

Van der Meer, Adriaan J. P. ^{[1
]}

机构：

[1] Erasmus MC, Rotterdam, Netherlands

[2] Amsterdam Univ Med Ctr, Amsterdam, Netherlands

[3] Univ Med Ctr Groningen, Groningen, Netherlands

[4] Leiden Univ Med Ctr, Leiden, Netherlands

[5] Reinier Graaf Gasthuis, Delft, Netherlands

[6] Noordwest Ziekenhuisgrp, Alkmaar, Netherlands

[7] Univ Med Ctr Utrecht, Utrecht, Netherlands

[8] St Antonius Hosp, Nieuwegein, Netherlands

[9] Catharina Hosp, Eindhoven, Netherlands

[10] Rijnstate, Arnhem, Netherlands

[11] Maastricht Univ Med Ctr, Maastricht, Netherlands

[12] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands

[13] Gelre Hosp, Zutphen, Netherlands

[14] Jeroen Bosch Hosp, Shertogenbosch, Netherlands

[15] Albert Schweitzer Hosp, Lambarene, Gabon

[16] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands

[17] Diakonessen Hosp, Utrecht, Netherlands

[18] Hosp Gelderse Vallei, Ede, Netherlands

[19] Med Ctr Leeuwarden, Leeuwarden, Netherlands

[20] Tergooi Hosp, Hilversum, Netherlands

[21] VieCuri, Venlo, Netherlands

[22] Canisius Wilhemina Hosp, Nijmegen, Netherlands

[23] Bernhoven, Uden, Netherlands

[24] Deventer Hosp, Deventer, Netherlands

[25] Med Ctr Haaglanden, The Hague, Netherlands

[26] Isala Hosp, Zwolle, Netherlands

来源：

HEPATOLOGY | 2024年 / 80卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2379

引用

页码：S1797 / S1798

页数：2

共 50 条

[1] The impact of ursodeoxycholic acid on biochemistry of patients with primary biliary cholangitis in a nationwide cohort
Werner, Ellen
van Hooff, Maria C.
van der Maas, Gerjan J.
de Veer, Rozanne C.
Beuers, Ulrich
Drenth, Joost P. H.
Cuperus, Frans J. C.
van Hoek, Bart
Veldt, Bart J.
Klemt-Kropp, Michael
van Meer, Suzanne
Verdonk, Robert C.
Flink, Hajo J.
Vrolijk, Jan Maarten
Gevers, Tom J. G.
Ponsioen, Cyriel Y.
de Kort, Sander
van Putten, Paul G.
Cahen, Djuna L.
van der Waaij, Lauren A.
Thio, Hans H. K.
Schreuder, Tim C. M. A.
van Dam, Lisette J. H.
Epping, Ludger S. M.
Jurgens, Matthias C.
Cazemier, Marcel
van Kemenade, J.
Kuiper, Edith M. M.
Beukema, Menno
ter Borg, Martijn J.
Soufidi, Khalida
Janssen, Harry L. A.
Hansen, Bettina E.
Erler, Nicole S.
van der Meer, Adriaan J.
JOURNAL OF HEPATOLOGY, 2024, 80 : S319 - S320
[2] Ursodeoxycholic acid in patients with primary biliary cholangitis
Numberger, Markus
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2024, 62 (01):
[3] Survival analysis and response to ursodeoxycholic acid in patients with primary biliary cholangitis
Raga, A.
Garcia-Retortillo, M.
Garcia-Rodriguez, A.
Broquetas, T.
Puigvehi, M.
Coll, S.
Gimeno, J.
Gimenez, M. D.
Bory, F.
Sola, R.
Carrion, J. A.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S352 - S352
[4] Treatment of primary biliary cirrhosis and primary sclerosing cholangitis: use of ursodeoxycholic acid.
Lee Y.M.
Kaplan M.M.
Current Gastroenterology Reports, 1999, 1 (1) : 38 - 41
[5] Treatment in primary biliary cholangitis: Beyond ursodeoxycholic acid
van Hooff, M. C.
Werner, E.
van der Meer, A. J.
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 124 : 14 - 21
[6] Bezafibrate for primary biliary Cholangitis "Bezafibrate in combination with ursodeoxycholic acid in primary biliary cholangitis (BEZURSO) trial"
Klose, G.
Nitschmann, S.
INTERNIST, 2018, 59 (12): : 1344 - 1346
[7] Effect of deferred or no treatment with ursodeoxycholic acid in patients with early primary biliary cholangitis
Tanaka, Atsushi
Hirohara, Junko
Nakano, Toshiaki
Yagi, Minami
Namisaki, Tadashi
Yoshiji, Hitoshi
Nakanuma, Yasuni
Takikawa, Hajime
HEPATOLOGY RESEARCH, 2018, 48 (09) : 727 - 734
[8] Determinants of the effectiveness of bezafibrate combined with ursodeoxycholic acid in patients with primary biliary cholangitis
Matsumoto, Kosuke
Hirohara, Junko
Takeuchi, Akihito
Miura, Ryo
Asaoka, Yoshinari
Nakano, Toshiaki
Tanaka, Atsushi
HEPATOLOGY RESEARCH, 2023, 53 (10) : 989 - 997
[9] EVALUATION OF PROGNOSTIC MODELS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS RECEIVING URSODEOXYCHOLIC ACID
Alomari, Mohammad
Covut, Fahrettin
Chadalavada, Pravallika
Gunasekaran, Deepthi
Padbidri, Vinay S.
Al Momani, Laith
Khazaaleh, Shrouq
Romero-Marrero, Carlos
GASTROENTEROLOGY, 2019, 156 (06) : S1321 - S1321
[10] Fenofibrate in Primary Biliary Cholangitis Patients With Inadequate Response to Ursodeoxycholic Acid (UDCA)
Khaykis, Inessa
Sherman, Alex
Tobias, Hillel
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S501 - S501

← 1 2 3 4 5 →